Viewing Study NCT00498992


Ignite Creation Date: 2025-12-24 @ 3:48 PM
Ignite Modification Date: 2026-01-05 @ 12:48 AM
Study NCT ID: NCT00498992
Status: UNKNOWN
Last Update Posted: 2013-09-20
First Post: 2007-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Sponsor: Ingalls Memorial Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module